Physical, Psychological and Socioeconomic Effects of Childhood Onset Diabetes in Sweden

Umeå University

Status: Active, not recruiting

Conditions: End-Stage Renal Disease; Type 1 Diabetes Mellitus (T1DM)

Study type: Observational

Funder types: Other

Identifiers

NCT06883318

2019-02492

Details and patient eligibility

About

The researchers study time trends of childhood-onset type 1 diabetes and its most serious complication, end-stage renal disease. They further analyse physical, psychological and socio-economic long-term effects on patients and families to identify potentially preventive factors in a population perspective. The researchers investigate the economic burden of disease and study and improve statistical methods for case-control data. The projects use a longitudinal nationwide database involving about 23 000 childhood-onset diabetes cases with maximum follow-up of 48 years and for each case 4 matched controls. The Swedish Childhood Diabetes Register is linked to a number of official, Swedish registers: the Renal register, the Cause of Death register, the National Patient register, the Prescribed Drugs register, the Cancer register and the Integrated Database for Labour Market Research. The researchers use GAM modelling for time trend analyses, standard case-control/cohort analyses, Cox regression for life table analyses, linear fixed effect probability for career development and propensity score models for confounding. The project group is multidisciplinary and involves experts in paediatrics, nephrology, epidemiology, health economics and statistics. This unique database and team continues to yield population-based new knowledge on the consequences of this increasingly common chronic childhood-onset disease.

Enrollment: 115,000 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Two prescriptions of insulin in the Prescribed Drug register.
• Age below 15 years of age. Controls are of the same age and born in the same municipality as the cases.

Exclusion criteria

• No

Trial design

115,000 participants in 2 patient groups

Cases with childhood-onset type 1 diabetes

Healthy controls